Quantum Computing Inc vs Tilray Brands Inc — how do they compare? Quantum Computing Inc trades at $8.05 (market cap $1.86B), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: Quantum Computing Inc is far larger — about 3.1× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.
| QUBT | TLRY | |
|---|---|---|
Market Cap | $1.86B | $591.60M |
Sector | Technology | Health |
52-Week High | $24.62 | $21.00 |
52-Week Low | $6.31 | $3.88 |
Enterprise Value | $927.53M | $758.73M |
Signals from Pluang's Aura AI — not financial advice
Quantum Computing Inc. (QUBT) trades at $8.22, up 2.62% today, amid bearish technical signals and challenging fundamentals. The company reported a net loss of $18.67 million on minimal revenue of $682,000 in 2025, with negative profit margins across all metrics. However, analyst sentiment remains optimistic with a 75% buy rating and $19 consensus price target, supported by recent government funding announcements and institutional investments from BlackRock and Bank of New York Mellon.
QUBT offers speculative growth potential in quantum computing but carries significant execution risks. The stock's 131% upside to analyst targets contrasts with persistent losses and high cash burn. Investors face volatility from unproven technology commercialization while banking on long-term quantum adoption. Key catalysts include contract wins and manufacturing scale-up, but profitability remains years away.
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
Trailing returns across standard periods
Latest headlines on both assets
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →